BIOMAT Database Logo BIOMAT Database Logo

Immunosuppressive therapy for myocarditis. 1995

B Maisch, and F Camerini, and H P Schultheiss

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Maisch, and F Camerini, and H P Schultheiss
Immunosuppressive therapy for myocarditis.
December 1995, The New England journal of medicine,
B Maisch, and F Camerini, and H P Schultheiss
Immunosuppressive therapy for myocarditis.
December 1995, The New England journal of medicine,
B Maisch, and F Camerini, and H P Schultheiss
Immunosuppressive therapy in myocarditis.
January 2015, Circulation journal : official journal of the Japanese Circulation Society,
B Maisch, and F Camerini, and H P Schultheiss
[Immunosuppressive therapy of myocarditis?].
April 1992, Herz,
B Maisch, and F Camerini, and H P Schultheiss
Combination Immunosuppressive Therapy for Giant Cell Myocarditis.
October 2022, Internal medicine (Tokyo, Japan),
B Maisch, and F Camerini, and H P Schultheiss
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.
August 1995, The New England journal of medicine,
B Maisch, and F Camerini, and H P Schultheiss
[Immunosuppressive therapy in myocarditis and dilated cardiomyopathy?].
October 1992, Der Internist,
B Maisch, and F Camerini, and H P Schultheiss
Giant cell myocarditis responding to immunosuppressive therapy.
March 2000, Chest,
B Maisch, and F Camerini, and H P Schultheiss
Immunosuppressive therapy in experimental and clinical myocarditis.
January 1988, Pathology and immunopathology research,
B Maisch, and F Camerini, and H P Schultheiss
Immunosuppressive Therapy and Interferon-1β in Acute Myocarditis.
November 2016, Revista espanola de cardiologia (English ed.),
Copied contents to your clipboard!